scispace - formally typeset
J

Jinyan Huang

Researcher at Shanghai Jiao Tong University

Publications -  125
Citations -  12348

Jinyan Huang is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Genome-wide association study & Gene. The author has an hindex of 41, co-authored 111 publications receiving 10304 citations. Previous affiliations of Jinyan Huang include Tongji University & Zhejiang University.

Papers
More filters

Genetic studies of body mass index yield new insights for obesity biology

Adam E. Locke, +481 more
TL;DR: This paper conducted a genome-wide association study and meta-analysis of body mass index (BMI), a measure commonly used to define obesity and assess adiposity, in up to 339,224 individuals.
Journal ArticleDOI

Effectiveness of convalescent plasma therapy in severe COVID-19 patients.

Kai Duan, +47 more
- 28 Apr 2020 - 
TL;DR: CP therapy was well tolerated and could potentially improve the clinical outcomes through neutralizing viremia in severe COVID-19 cases and the optimal dose and time point, as well as the clinical benefit of CP therapy, needs further investigation in larger well-controlled trials.
Journal ArticleDOI

The genetic architecture of type 2 diabetes

Christian Fuchsberger, +349 more
- 11 Jul 2016 - 
TL;DR: In this paper, the authors performed whole-genome sequencing in 2,657 European individuals with and without diabetes, and exome sequencing for 12,940 individuals from five ancestry groups.

The genetic architecture of type 2 diabetes

Christian Fuchsberger, +300 more
TL;DR: Large-scale sequencing does not support the idea that lower-frequency variants have a major role in predisposition to type 2 diabetes, but most fell within regions previously identified by genome-wide association studies.
Journal ArticleDOI

Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China

Huwen Wang, +14 more
- 24 Feb 2020 - 
TL;DR: Regardless of the occurrence of the peak, the currently strict measures in Wuhan should be continuously implemented and necessary strict public health measures should be applied in other locations in China with high number of COVID-19 cases in order to reduce R t to an ideal level and control the infection.